NCT04050072 Patient-Reported Outcome Version of the Common Criteria for Adverse Events Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04047901 Effect of Physical Training in Patients With Heart Failure Caused by Chemotherapy for Cancer Treatment Status UNKNOWN Phase NA
NCT04044040 Symptom Screening With Targeted Early Palliative Care (STEP) for Patients With Advanced Cancer Status COMPLETED Phase NA
NCT04040881 Accuracy of a Mobile Sensor-Based System for the Detection of Chemotherapy Toxicity in Older Adults With Cancer in a Developing Country Status COMPLETED Phase NA
NCT04039425 Effects of Chemotherapy on the Concentration of Minerals in Hair Status COMPLETED Phase N/A
NCT04038996 The Role of SNP rs2910164 in Patients Treated With Immune Checkpoint Inhibitors Status COMPLETED Phase N/A
NCT04037436 Functional Exercise and Nutrition Education Program for Older Adults Status COMPLETED Phase NA
NCT04036032 Role of Aerobic Exercise to Modulate Cardiotoxicity in Long Term Cancer Survivors Exposed to Anthracycline Therapy Status COMPLETED Phase N/A
NCT04031469 A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease Status SUSPENDED Phase N/A
NCT04030572 Feasibility of Administering Clonidine as a Pharmacological Challenge in Imaging Studies Status TERMINATED Phase EARLY_PHASE1
NCT04026659 The Feasibility of Implementing an Exercise Programme for Deconditioned Cancer Survivors Status COMPLETED Phase NA
NCT04026048 Online Treatment of Cognitive Impairment and Insomnia in Cancer Survivors Status COMPLETED Phase NA
NCT04025970 Molecular Analysis of Blood Samples in Standardized Cancer Care Referrals for SCAN and CUP Status UNKNOWN Phase N/A
NCT04020029 Leveraging Mindsets to Improve Health and Wellbeing in Patients With Cancer Status WITHDRAWN Phase NA
NCT04018677 TOGETHER: Track Outcomes and Guidance, Technology for Health and Effective Resources Status COMPLETED Phase NA
NCT04017819 Biodistribution&Pharmacokinetic of Position Emission Tomography(PET) Radiopharmaceutical 18F C SNAT4 Status SUSPENDED Phase PHASE1
NCT04016116 Dual PD-1 and JAK2 Inhibition in Hematological Malignancies Status WITHDRAWN Phase PHASE2